Literature DB >> 18522504

Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats.

Xi Yang1, Rebecca A Buonpane, Beenu Moza, A K M Nur-ur Rahman, Ningyan Wang, Patrick M Schlievert, John K McCormick, Eric J Sundberg, David M Kranz.   

Abstract

Staphylococcus aureus secretes various toxins that act as superantigens by stimulating a large fraction of the host's T cells. Toxin binding to variable domains of T cell receptor beta chains (Vbeta) leads to massive release of inflammatory molecules and potentially to toxic shock syndrome (TSS). Previously, we generated soluble forms of different Vbeta domains with a high affinity for binding superantigens. However, a broader spectrum antagonist is required for the neutralization of multiple toxins. In the present study, we expressed Vbeta domains in tandem as a single-chain protein and neutralized the clinically important superantigens staphylococcal enterotoxin B and TSS toxin-1 with a single agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522504      PMCID: PMC2649774          DOI: 10.1086/589776

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Domain antibodies: proteins for therapy.

Authors:  Lucy J Holt; Chris Herring; Laurent S Jespers; Benjamin P Woolven; Ian M Tomlinson
Journal:  Trends Biotechnol       Date:  2003-11       Impact factor: 19.536

2.  Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.

Authors:  James W Boles; M Louise M Pitt; Ross D LeClaire; Paul H Gibbs; Edna Torres; Beverly Dyas; Robert G Ulrich; Sina Bavari
Journal:  Clin Immunol       Date:  2003-07       Impact factor: 3.969

3.  Molecular basis of TCR selectivity, cross-reactivity, and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vbeta2.1 molecular interface.

Authors:  A K M Nur-ur Rahman; Christine A Herfst; Beenu Moza; Stephanie R Shames; Luan A Chau; Clara Bueno; Joaquín Madrenas; Eric J Sundberg; John K McCormick
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

4.  Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists.

Authors:  Rebecca A Buonpane; Hywyn R O Churchill; Beenu Moza; Eric J Sundberg; Marnie L Peterson; Patrick M Schlievert; David M Kranz
Journal:  Nat Med       Date:  2007-05-21       Impact factor: 53.440

5.  Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens.

Authors:  B Fleischer; A Necker; C Leget; B Malissen; F Romagne
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  "Diabodies": small bivalent and bispecific antibody fragments.

Authors:  P Holliger; T Prospero; G Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 7.  Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

Authors:  G A Bohach; D J Fast; R D Nelson; P M Schlievert
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

Review 8.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

9.  Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.

Authors:  Y Choi; J A Lafferty; J R Clements; J K Todd; E W Gelfand; J Kappler; P Marrack; B L Kotzin
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

Review 10.  The evolving field of biodefence: therapeutic developments and diagnostics.

Authors:  James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

View more
  13 in total

1.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

Review 2.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

3.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

Review 4.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

5.  Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.

Authors:  Avanish K Varshney; Xiaobo Wang; Matthew D Scharff; Jennifer MacIntyre; Richard S Zollner; Oleg V Kovalenko; Luis R Martinez; Fergus R Byrne; Bettina C Fries
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

Review 6.  Recent insights into atopic dermatitis and implications for management of infectious complications.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

Review 7.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 8.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B.

Authors:  Brian Drozdowski; Yuhong Zhou; Brad Kline; Jared Spidel; Yin Yin Chan; Earl Albone; Howard Turchin; Qimin Chao; Marianne Henry; Jacqueline Balogach; Eric Routhier; Sina Bavari; Nicholas C Nicolaides; Philip M Sass; Luigi Grasso
Journal:  J Immune Based Ther Vaccines       Date:  2010-12-21

Review 10.  Staphylococcal enterotoxins.

Authors:  Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  Toxins (Basel)       Date:  2010-08-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.